ArticleJournal of pharmacology & pharmacotherapeutics2011

Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus.

Darshan J DavePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.